We compared the in vitro effects of 4 representative AML oncogenes, PML-RARA, AML1-ETO, MLL-AF9 and NUP98-HOXA9, on the differentiation, proliferation, and self-renewal of primary human CD34+ cells under identical conditions. The gene discussed is KMT2A; the disease is acute myeloid leukemia.